COVID-19
4Curable or preventable in mostAI-generated
Burden-over-time charts — how many people this disease affects and whether that number is rising or falling — are coming to this page. The treatability read, milestones, and live trial pipeline below are current.
Milestones
dot size = significance- 2001Anakinra approved (FDA)
- 2005Tocilizumab approved (FDA)
- 2020Remdesivir approved (FDA)
- 2020Tozinameran approved (FDA)
- 2021Elasomeran approved (FDA)
- 2021Adenovirus type 26 encoding sars-cov-2 spike glycoprotein approved (FDA)
- 2021Sars-cov-2 virus spike protein approved (FDA)
- 2021Regdanvimab approved (FDA)
- 2021Sotrovimab approved (FDA)
- 2021Chimpanzee adenovirus encoding sars-cov-2 spike glycoprotein approved (FDA)
What's being tested now
Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.
See all 433 active COVID-19 trials on Clin2 →